Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
British Journal of Pharmacology|July 27, 2019
Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphineLucja Kudla, Ryszard Bugno, Urszula Skupio, et al.Molecules (Basel, Switzerland)|August 7, 2021
N-Skatyltryptamines-Dual 5-HT6R/D2R Ligands with Antipsychotic and Procognitive PotentialAgata Hogendorf, Adam S Hogendorf, Rafał Kurczab, et al.Scientific Reports|May 6, 2017
Low-basicity 5-HT7 Receptor Agonists Synthesized Using the van Leusen Multicomponent ProtocolAdam S Hogendorf, Agata Hogendorf, Rafał Kurczab, et al.European Journal of Medicinal Chemistry|November 18, 2019
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive propertiesJakub Staroń, Rafał Kurczab, Dawid Warszycki, et al.Journal of Medicinal Chemistry|September 1, 2021
Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive PropertiesPaweł Zajdel, Katarzyna Grychowska, Szczepan Mogilski, et al.International Journal of Molecular Sciences|February 11, 2023
Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like PropertiesKatarzyna Kaczorowska, Anna Stankiewicz, Ryszard Bugno, et al.European Journal of Medicinal Chemistry|June 24, 2019
2-Aminoimidazole-based antagonists of the 5-HT6 receptor - A new concept in aminergic GPCR ligand designAdam S Hogendorf, Agata Hogendorf, Rafał Kurczab, et al.European Journal of Medicinal Chemistry|March 25, 2019
Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillersAdam S Hogendorf, Agata Hogendorf, Katarzyna Popiołek-Barczyk, et al.Pageof 4